What is ECRI?
ECRI operates as an independent, nonprofit entity dedicated to the rigorous evaluation of medical technology and the advancement of patient safety. By maintaining strict conflict-of-interest policies, the organization has solidified its reputation as a neutral arbiter in healthcare decision-making. Its core competencies include the operation of advanced testing laboratories across North America and the Asia Pacific, as well as its designation as a federally certified Patient Safety Organization. Following the 2020 affiliation with the Institute for Safe Medication Practices (ISMP), ECRI has further consolidated its market position, providing comprehensive, data-driven insights that influence clinical outcomes and cost-effectiveness across diverse healthcare settings.
How much funding has ECRI raised?
ECRI has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in ECRI
PPP
Public-Private Partnership
What's next for ECRI?
With the deployment of this strategic capital, ECRI is positioned to accelerate its digital transformation and enhance its evidence-based practice frameworks. The organization is expected to leverage these resources to deepen its technological decision support tools, ensuring that healthcare leaders remain equipped with the most current, validated data. As the industry faces increasing pressure to optimize costs while improving patient outcomes, ECRI's focus on independent research and safety standards will likely serve as a cornerstone for future healthcare policy and operational excellence. The firm remains committed to its mission of improving the safety and quality of care through its unique, research-heavy methodology.
See full ECRI company page
